- Business Wire•15 days ago
InVivo Therapeutics Holdings Corp. today announced that Mark Perrin, Chief Executive Officer and Chairman, will present at the 2017 BIO CEO & Investor Conference on Monday, February 13, 2017 at 11:30 A.M.
- Investopedia•28 days ago
InVivo said interim results suggest its Neuro-Spinal Scaffold can help treat spinal cord injury.
- Zacks•29 days ago
On Tuesday, shares of medical device company InVivo Therapeutics (NVIV) are gaining big, up almost 15% in afternoon trading on news that a patient in its INSPIRE study has significantly improved.
NVIV : Summary for INVIVO THERAPEUTICS - Yahoo Finance
InVivo Therapeutics Holdings Corp. (NVIV)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||4.00 x 1000|
|Ask||6.10 x 300|
|Day's Range||4.35 - 4.58|
|52 Week Range||4.00 - 10.36|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-5.97|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|